The Globe and Mail reports in its Tuesday, Aug. 22, edition that Stifel analyst Martin Landry has reaffirmed his "buy" recommendation for Dollarama. The Globe's David Leeder writes in the Eye On Equities column that Mr. Landry is sticking with his $96 share target. Analysts on average target the shares at $91.18. The Globe says Mr. Landry expects the discount retailer to raise its full-year same-store growth forecast when it reports its second quarter 2024 financial results on Sept. 13. Mr. Landry says in a note: "We analyzed more than 4,000 SKUs to assess the pace of the $4-plus product roll-out, and we reviewed our basket of 71 legacy products to determine the extent of inflation passed to customers. Our analysis suggests that the roll-out of the $4-plus products is progressing well with 15 per cent of Dollarama's products priced above $4, 800 basis points higher than in September, 2022. Additionally, our analysis of Dollarama's legacy products suggests that prices are 4.3 per cent higher year-over-year, which bodes well for SSS growth." The Globe reported on June 9 that Canaccord Genuity analyst Derek Dley had reaffirmed his "hold" recommendation for Dollarama when it could be had for $82.87.